AbbVie Inc. (NYSE:ABBV) Q2 2022 Earnings Conference Call July 29, 2022 9:00 AM ET
Company Participants
Liz Shea - Head, IR
Rick Gonzalez - Chairman and CEO
Rob Michael - Vice Chairman and President
Jeff Stewart - EVP and Chief Commercial Officer
Tom Hudson - SVP R&D, and Chief Scientific Officer
Carrie Strom - SVP, and President, Global Allergan Aesthetics
Neil Gallagher - VP and Chief Medical Officer
Roopal Thakkar - Vice President, Global Regulatory Affairs
Conference Call Participants
Andrew Baum - Citi
Terence Flynn - Morgan Stanley
Mohit Bansal - Wells Fargo
Gary Nachman - BMO Capital Markets
Chris Schott - J.P. Morgan
Steve Scala - Cowen
Chris Raymond - Piper Sadler
Tim Anderson - Wolfe Research
Geoff Meacham - Bank of America
Colin Bristow - UBS
Chris Shibutani - Goldman Sachs
David Risinger - SVB Securities
Operator
Good morning, and thank you for standing by. Welcome to the AbbVie Second Quarter 2022 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions]
I would now like to introduce Ms. Liz Shea, Vice President, Head of Investor Relations.
Liz Shea
Good morning, and thanks for joining us.
Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Rob Michael, Vice Chairman and President; Jeff Stewart, Executive Vice President, Chief Commercial Officer; and Tom Hudson, Senior Vice President, R&D, and Chief Scientific Officer. Joining us for the Q&A portion of the call are Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer and Corporate Secretary; Carrie Strom, Senior Vice President and President of Global Allergan Aesthetics; Scott Reents, Senior Vice President and Chief Financial Officer; Neil Gallagher, Vice President and Chief Medical Officer; and Roopal Thakkar, Vice President, Global Regulatory Affairs.
Before
- Read more current ABBV analysis and news
- View all earnings call transcripts